ChitogenX Inc. CHGX

Company Overview

ChitogenX Inc. (ticker: CHGX) is a Canadian biotechnology and regenerative medicine company focused on the development of tissue repair and wound-healing technologies. The company operates in the healthcare and life sciences sectors, with activities centered on biomaterials, regenerative therapeutics, and surgical recovery applications. Its core technology platform is based on proprietary chitosan-based biomaterials designed to support tissue regeneration, hemostasis, and healing in orthopedic, dermatological, and wound-care settings.

The company’s principal business activities have historically included the development and commercialization of biologic and biomaterial products for soft tissue repair and chronic wound management. ChitogenX evolved from earlier regenerative medicine and orthopedic-focused operations and has undergone strategic restructuring and rebranding initiatives as it shifted toward broader regenerative health applications. Public filings and corporate disclosures indicate that the company has pursued partnerships and licensing arrangements to expand the clinical and commercial use of its proprietary technologies.